Professor Yingli Sun obtained her Ph.D degree in cell and molecular biology from Peking University, Beijing, P.R. China, in 2000. Between 2000 and 2002, she joined Massachusetts Institute of Technology, Cambridge, MA, U.S to do her postdoctoral research and then work as Assistant Professor in Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, U.S from 2002-2010. By 2010, she was selected as 100 Talents Program Scholar and honored the Second “SCOPUS” for Youth Science star" Growth Award, Chinese Academy of Sciences Youth Federation and the Communist Youth League (Second place in national life sciences field). she published about 30 scientific papers in high impact journals such as NCB, JCB, MCB, PNAS.
Professor Sun’s research activities are mainly involved in the following four areas: 1) Genomic stabilities of cancer cells and stem cells. 2) Epigenetic modification patterns of prostate cancer and breast cancer. 3) Epigenetic regulation of cancer and stem cells and the regulating mechanism. 4) Drug design and screening targeted to cancer or cancer stem cells. Over the past several years, she and her laboratory have made breakthrough in genomic stability and epigenetic regulation research. She also made great contribution and did excellent research work in epigenetic regulation study of cancer and stem cells.
